Wan kwɛstyɔn we kin kam na in maynd at le wan tɛm na ɛnibɔdi we de gɛt tritmɛnt fɔ in bɔdi kansa na, ‘Dis sik dɔn dɔn kpatakpata naw?’ Da fred de rili mek sɛns. Bɔt di gud nyus na dat, bɔku tɛm, bɔdi kansa nɔ kin kam bak. Bɔt, sɔntɛnde i kin ebul.
If i kam bak, wi kin kɔl am ‘ rikɔrɛshɔn’ . Bɔku we dɛn de we dis kin apin. Wan na dat i kin kam bak na di sem brɔst we di fɔs kansa bin gɛt ɔ na say we de nia de. Sɔntɛnde i kin spre to di limf no dɛm we de nia de. Ɔda tɛm dɛn, i kin go na di say dɛn we de fa fawe na di bɔdi, lɛk di bon dɛn ɔ di lɔng dɛn.
Wetin di dɔktɔ de pe atɛnshɔn pan?
Frɔm di tɛm we dɛn fɔs no se yu gɛt bɔdi kansa, yu dɔktɔ dɛn go chɛk fɔ tin dɛn we de mek yu gɛt mɔ risk fɔ mek i kam bak. Dis infɔmeshɔn go ɛp dɛn fɔ disayd us tritmɛnt go fayn fɔ yu.
"Wi nɔ go ebul fɔ tɔk wit 100% shɔ se kansa go kam bak. Bɔt naw wi kin prɛdikt am wit bɔku ay prɔbabiliti pas bifo," na so wan spɛshal pɔsin se.
Big big advans dεm dכn de pan dis fil fכ di pas 10 ia, spεshal wan pan εstrojen -rεsεptor positifu kεnsar dεm.
Fɔ tɔk am simpul wan, di mɔ di tumbu big, na di mɔ i dɔn skata to ɔda tisu dɛn, na di mɔ i go kam bak. Dɔn bak, di bayoloji fɔ di kansa rili impɔtant. dat min se, us spεsifi k rεsεpכta dεm de pan di kεnsar sεl dεm. fכ egzampl, wan kayn brεst kεnsar we dεn kכl ``triple-negative'' (dat na, kεnsar we nכ gεt כl di tri rεsεpכta dεm fכ εstrojen, projεstεron, εn HER2) kin kam bak sכmtεm.
| Tin dɛm fɔ tink bɔt we yu de asɛs di risk | Wetin mek dat impɔtant? |
|---|---|
| Yu ej ɛn if yu dɔn go tru menopause | Di ej ɛn di ɔmon lɛvɛl kin afɛkt di risk. |
| Tumɔr saiz | big tכmכro dεm kin jεnarali asosiet wit hכy risk fכ rikarεshכn. |
| If i dɔn spre to di limf no dɛm | di prεsεns fכ kεnsar sεl dεm na di stכl de sho se kansa kin spεd. |
| Riseptɔ stetɔs fɔ kansa | Di tritmɛnt ɛn risk kin difrɛn difrɛn wan fɔ no if di kansa na ER-positiv, PR-positiv, HER2-positiv, ɔ triple-negative. |
Spɛshal tɛst dɛm wae de luk mɔr dip wan pan de risk
Sɔntɛnde, if di kansa rili big ɔ i dɔn skata to di limf no dɛm, i nɔ kin izi fɔ tɔk klia wan wetin na di risk. Dɔktɔ dɛn kin kɔl dis ‘grey zon.’
Insay kes dɛn lɛk dis, spɛshal tɛst dɛn de we kin gi mɔ infɔmeshɔn . Bɔt nɔto ɔl dɛn tɛst ya fayn fɔ ɔl kayn kansa.
- Oncotype DX: Dis na di tɛst we dɛn kin yuz mɔ. I de luk pan 21 jin dɛm na wan smɔl sampul fɔ yu kansa. Dipen pan aw dɛn jin ya de wok fayn, yu kin gɛt ‘rikɔrɛshɔn skɔ’ bitwin 0 ɛn 100. Dis skɔ kin ɛp yu dɔktɔ fɔ ɔndastand aw yu kansa go kam bak tumara bambay ɛn if yu go bɛnifit frɔm kemotɛrapi. כltu, dεn kin כnli du dis tεst fכ kεnsar dεm we εstrojen-rεsεptor positifu εn we nכ spre to di limf no dεm.
- כda tεst dεm: Tεst dεm de bak we dεn kכl `(MammaPrint)`, `(Breast Cancer Index)`, `(Pam50)`, εn `(EndoPredict)`. Sɔm pan dɛn tin ya kin ɛp fɔ no di risk fɔ gɛt kansa fɔ kam bak afta fayv ia.
Di blɔd tɛst dɛn we dɛn go du tumara bambay
Naw, wan grup we de stɔdi bɔt dis de tray fɔ mek wan blɔd tɛst we go no if kansa go kam bak.
Dis kayn tɛst rili impɔtant afta ɔl di tritmɛnt dɛn dɔn, we nɔr kansa tisu nɔr de fɔ ɛgzamin.
Wan pan di sayɛnsman dɛn we de du di risach bin tɔk se: "If wi ebul fɔ no gud gud wan udat go gɛt di kansa bak, wi kin disayd if dɛn nid ɔda tritmɛnt. Dɔn wi kin bigin fɔ du risach bɔt nyu tritmɛnt dɛn we go wok fɔ dɛn kwik kwik wan." "Wi ɔltimat gol na fɔ mek dɛn nɔ gɛt mɛtastas brɔst kansa, we at fɔ manej ɛn we de mek 90% pan di pipul dɛn we de day wit brɔst kansa."
Bɔt dɛn se i go tek sɔm ia mɔ fɔ mek dɛn mek wan blɔd tɛst we dɔktɔ dɛn go yuz .
Wetin yu go du?
Te sayɛnsman dɛn fɛn nyu tɛst dɛn lɛk dis, tin dɛn de we yu go ebul fɔ du. Di tin dɛn we yu kin du ɛvride kin ɛp fɔ ridyus dis prɔblɛm. Fɔ ɛgzampul, i impɔtant fɔ de ɛksesaiz ɔltɛm ɛn fɔ mek yu gɛt wɛlbɔdi .
Wan ɔda tin we wi fɔ mɛmba na dat di risk fɔ mek i gɛt dis sik bak ɛn di rit we pɔsin kin liv na tu difrɛn tin dɛn . Dis rili impɔtant. Imajin sɔmbɔdi we gɛt bɔdi kansa, gɛt tritmɛnt, dɔn di kansa kam bak tu ia afta dat. Bɔt if dɛn fɛn am kwik, da pɔsin de kin liv fayn fɔ bɔku bɔku ia.
So, nɔ mis ɛni wan pan yu fɔlɔp apɔntinmɛnt dɛn . If yu gɛt ɛni kwɛstyɔn ɔ tin we de mɔna yu, mek shɔ se yu aks yu dɔktɔ.
"I impɔtant fɔ tɔk to yu dɔktɔ ɛn ɔndastand gud gud wan wetin na yu pasɔnal risk ɛn wetin i min. Dis go ɛp yu fɔ disayd di rayt tin bɔt yu tritmɛnt. Fɔ dil wit kansa kin bi sɔntin we de mek yu fred, we kin mek yu kɔnfyus. So yu nid fɔ fil fayn fɔ tɔk to yu dɔktɔ bɔt wetin yu de fred."
Mɛsej we dɛn kin kɛr go na os
- Bɔrku tɛm, bɔrku kansa nɔr kin kam bak afta yu dɔn trit yu, so nɔr frayd fɔ wae yu nɔr nid.
- Di risk fɔ mek kansa kam bak de dipen pan tin dɛm lɛk di saiz fɔ di tumbu, di spred to di tisu dɛm we de nia am, ɛn di bayolojikal kayn kansa.
- Fɔ no di rayt risk ɛn pik di bɛst tritmɛnt, dɔktɔ dɛn kin yuz spɛshal tɛst lɛk Oncotype DX.
- Yu kin ɛp bak fɔ ridyus dis prɔblɛm bay we yu de du ɛksɛsayz ɔltɛm ɛn mek yu bɔdi gɛt wɛlbɔdi.
- Di tin we impɔtant pas ɔl na fɔ tɔk to yu dɔktɔ opin wan. Lisin to ɔl di tin dɛn we yu de fred ɛn di kwɛstyɔn dɛn we yu de aks. I rili impɔtant bak fɔ yu maynd wɛl bɔdi.











💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt